Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group

被引：0
|
作者：
Keiji Tsuji
Masayuki Kurosaki
Jun Itakura
Nami Mori
Shintaro Takaki
Chitomi Hasebe
Takehiro Akahane
Kouji Joko
Hitoshi Yagisawa
Jirou Takezawa
Ryou Nakata
Atsunori Kusakabe
Yuji Kojima
Hiroyuki Kimura
Takashi Tamada
Haruhiko Kobashi
Akeri Mitsuda
Masahiko Kondou
Chikara Ogawa
Yasushi Uchida
Tetsuro Sohda
Ryouichi Narita
Namiki Izumi
机构：
[1] Hiroshima Red Cross Hospital and Atomic-bomb Survivors Hospital,Department of Gastroenterology
[2] Musashino Red Cross Hospital,Department of Gastroenterology and Hepatology
[3] Japanese Red Cross Asahikawa Hospital,Department of Gastroenterology
[4] Japanese Red Cross Ishinomaki Hospital,Department of Gastroenterology
[5] Matsuyama Red Cross Hospital,Center for Liver
[6] Japanese Red Cross Akita Hospital,Biliary
[7] Japanese Red Cross Haramachi Hospital,Pancreatic Disease
[8] Japanese Red Cross Medical Center,Department of Gastroenterology
[9] Japanese Red Cross Nagoya Daini Hospital,Department of Internal Medicine
[10] Japanese Red Cross Ise Hospital,Department of Gastroenterology
[11] Japanese Red Cross Kyoto Daiichi Hospital,Department of Gastroenterology
[12] Takatsuki Red Cross Hospital,Department of Hepatology
[13] Japanese Red Cross Okayama Hospital,Department of Gastroenterology
[14] Japanese Red Cross Tottori Hospital,Department of Gastroenterology
[15] Japanese Red Cross Otsu Hospital,Department of Gastroenterology
[16] Takamatsu Red Cross Hospital,Department of Gastroenterology
[17] Matsue Red Cross Hospital,Department of Gastroenterology
[18] Japanese Red Cross Fukuoka Hospital,Department of Gastroenterology
[19] Oita Red Cross Hospital,Department of Gastroenterology
来源：
Journal of Gastroenterology | 2018年 / 53卷
关键词：
Chronic hepatitis C; Ledipasvir; Sofosbuvir; Alpha-fetoprotein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1142 / 1150
页数：8
相关论文
共 50 条
  • [1] Real-world efficacy and safety of ledipasvir and sofosbuvir in patients with hepatitis C virus genotype 1 infection: a nationwide multicenter study by the Japanese Red Cross Liver Study Group
    Tsuji, Keiji
    Kurosaki, Masayuki
    Itakura, Jun
    Mori, Nami
    Takaki, Shintaro
    Hasebe, Chitomi
    Akahane, Takehiro
    Joko, Kouji
    Yagisawa, Hitoshi
    Takezawa, Jirou
    Nakata, Ryou
    Kusakabe, Atsunori
    Kojima, Yuji
    Kimura, Hiroyuki
    Tamada, Takashi
    Kobashi, Haruhiko
    Mitsuda, Akeri
    Kondou, Masahiko
    Ogawa, Chikara
    Uchida, Yasushi
    Sohda, Tetsuro
    Narita, Ryouichi
    Izumi, Namiki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (10) : 1142 - 1150
  • [2] Real-world efficacy and safety of sofosbuvir plus ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
    Akahane, Takehiro
    Kurosaki, Masayuki
    Itakura, Jun
    Tsuji, Keiji
    Joko, Kouji
    Kimura, Hiroyuki
    Nasu, Akihiro
    Ogawa, Chikara
    Kojima, Yuji
    Hasebe, Chitomi
    Wada, Shuichi
    Uchida, Yasushi
    Sohda, Tetsuro
    Suzuki, Hideyuki
    Yoshida, Hideo
    Kusakabe, Atsunori
    Tamada, Takashi
    Kobashi, Haruhiko
    Mitsuda, Akeri
    Kondo, Masahiko
    Shigeno, Masaya
    Ide, Yasushi
    Morita, Atsuhiro
    Kitamura, Tadashi
    Abe, Takehiko
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2019, 49 (03) : 264 - 270
  • [3] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Toshifumi Tada
    Takashi Kumada
    Hiroaki Okushin
    Joji Tani
    Koichi Takaguchi
    Akemi Tsutsui
    Hidenori Toyoda
    Satoshi Yasuda
    Kazufumi Dohmen
    Atsushi Hiraoka
    Kojiro Michitaka
    Kazuhiro Nouso
    Kazuya Kariyama
    Soo Ryang Kim
    Soo Ki Kim
    Shinichi Fujioka
    Shigeru Mikami
    Yuto Watanabe
    Tsutomu Tamai
    Masanori Atsukawa
    Norio Itokawa
    Hironori Tanaka
    Kunihiko Tsuji
    Toru Ishikawa
    Michitaka Imai
    Ei Itobayashi
    Hiroshi Shibata
    Noritomo Shimada
    Infectious Diseases and Therapy, 2021, 10 : 269 - 280
  • [4] Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study
    Tada, Toshifumi
    Kumada, Takashi
    Okushin, Hiroaki
    Tani, Joji
    Takaguchi, Koichi
    Tsutsui, Akemi
    Toyoda, Hidenori
    Yasuda, Satoshi
    Dohmen, Kazufumi
    Hiraoka, Atsushi
    Michitaka, Kojiro
    Nouso, Kazuhiro
    Kariyama, Kazuya
    Kim, Soo Ryang
    Kim, Soo Ki
    Fujioka, Shinichi
    Mikami, Shigeru
    Watanabe, Yuto
    Tamai, Tsutomu
    Atsukawa, Masanori
    Itokawa, Norio
    Tanaka, Hironori
    Tsuji, Kunihiko
    Ishikawa, Toru
    Imai, Michitaka
    Itobayashi, Ei
    Shibata, Hiroshi
    Shimada, Noritomo
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (01) : 269 - 280
  • [5] Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
    Mashiba, Toshie
    Joko, Kouji
    Kurosaki, Masayuki
    Ochi, Hironori
    Hasebe, Chitomi
    Akahane, Takehiro
    Sohda, Tetsuro
    Tsuji, Keiji
    Mitsuda, Akeri
    Kimura, Hiroyuki
    Narita, Ryoichi
    Ogawa, Chikara
    Furuta, Koichiro
    Shigeno, Masaya
    Okushin, Hiroaki
    Ito, Hiroshi
    Kusakabe, Atsunori
    Satou, Takashi
    Kawanami, Chiharu
    Nakata, Ryo
    Kobashi, Haruhiko
    Tamada, Takashi
    Ide, Yasushi
    Yagisawa, Hitoshi
    Morita, Atsuhiro
    Matsushita, Tomomichi
    Okada, Kazuhiko
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2019, 49 (10) : 1114 - 1120
  • [6] Real-world efficacy of elvasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group
    Mashiba, Toshie
    Joko, Kouji
    Ochi, Hironori
    Yano, Ryo
    Sato, Kaori
    Okujima, Yusuke
    Aono, Michiko
    Azemoto, Nobuaki
    Yokota, Tomoyuki
    Kurosaki, Masayuki
    Izumi, Namiki
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E232 - E232
  • [7] Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
    Liu, Chen-Hua
    Liu, Chun-Jen
    Su, Tung-Hung
    Yang, Hung-Chih
    Hong, Chun-Ming
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Chen, Ding-Shinn
    Kao, Jia-Horng
    PLOS ONE, 2018, 13 (12):
  • [8] Real-world safety and effectiveness of ledipasvir/sofosbuvir for the treatment of chronic hepatitis C virus genotype 1 in Japan
    Mizokami, Masashi
    Liu, Lauren J.
    Fujiyama, Naoto
    Littman, Marcus
    Yuan, Jason
    Sekiya, Tomoko
    Hedskog, Charlotte
    Ng, Leslie J.
    JOURNAL OF VIRAL HEPATITIS, 2021, 28 (01) : 129 - 141
  • [9] Real-World Retreatment of Sofosbuvir/Ledipasvir (SOF/LDV) Failures In Hepatitis C Virus Genotype 1 infection
    Pearlman, Brian
    Hinds, Andrew
    Perrys, Michael
    HEPATOLOGY, 2016, 64 : 478A - 478A
  • [10] Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
    Baatarkhuu, Oidov
    Lee, Jae Seung
    Amarsanaa, Jazag
    Kim, Do Young
    Ahn, Sang Hoon
    Naranzul, Nyamsuren
    Enkhtuya, Damba
    Choijamts, Nagir
    Batbayar, Purev
    Otgonbayar, Radnaa
    Saruul, Bat-Ulzii
    Gantuul, Chuluunbaatar
    Gegeebadrakh, Baljinnyam
    Tuvshinbayar, Narangerel
    Badamsuren, Dorjgotov
    Ulzmaa, Galsan
    Otgonbold, Jamiyandorj
    Han, Kwang-Hyub
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (01) : 125 - 135
12345